AI isn’t close to curing cancer. Vivodyne says it knows what it will take; plus, TerraPower’s nuclear reactor has a secret weapon for powering AI data centers
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
A handful of AI-designed drugs have proceeded into human trials — one as far as Phase III, widespread human testing — but the reality is that the roadblocks aren’t necessarily ones that AI can solve today.
Also, TerraPower's nuclear power plant possesses a strategic advantage over competitors, especially when chasing after data center deals. Learn more about your ad choices. Visit podcastchoices.com/adchoices
